The EASL™ Congress (EASL) provides the latest, cutting-edge advances in liver disease research, prevention, and care. The program is categorized by specific liver disease including HBV, HCV, ALD, and NAFLD, where CVrg’s focus is on NAFLD; each indication is organized into themes allowing attendees to focus on specific interests including: Clinical aspects except therapy, Therapeutics, and Diagnostics and non-invasive assessment. EASL typically releases abstract titles for the final program 4 weeks before conference start, while abstracts are released 1-2 weeks prior to conference start.